Skip to main content

Articles

1199 result(s) for 'cancer' within Journal of Ovarian Research

Page 23 of 24

  1. Since ovarian cancer is associated with high frequency of p53...p 53 r eactivation and i nduction of m assive a...poptosis (PRIMA-1) offers a possible new therapeutic strategy for overcoming this devastating dise...

    Authors: Noriko Kobayashi, Mohammadreza Abedini, Noriaki Sakuragi and Benjamin K Tsang
    Citation: Journal of Ovarian Research 2013 6:7
    Content type: Research Published on:

  2. Anti-Her-2 treatment is successfully administered to Her-2 overexpressing breast cancer patients and significantly implicates upon their survival. ... were tested as an option for epithelial ovarian cancer (EOC) ...

    Authors: Sabine Heublein, Thomas Vrekoussis, Doris Mayr, Klaus Friese, Miriam Lenhard, Udo Jeschke and Darius Dian
    Citation: Journal of Ovarian Research 2013 6:6
    Content type: Brief communication Published on:

  3. Epithelial ovarian cancer is one of the leading causes of gynaecological cancer morbidity and mortality in women. Early stage ovarian cancer is usually asymptomatic, therefore, is often ... localisation and plasm...

    Authors: Ratana Lim, Martha Lappas, Clyde Riley, Niels Borregaard, Holger J Moller, Nuzhat Ahmed and Gregory E Rice
    Citation: Journal of Ovarian Research 2013 6:5
    Content type: Research Published on:

  4. There is a clinical need for routinely available genomic biomarker testing in newly diagnosed ovarian cancer. In the current study we performed molecular ... prognostic biomarkers in archival diagnostic tissue fr...

    Authors: Shelly Gunn, Xavier Reveles, Korrie Weldon, Andres Barrera, Mariam Ishaque, Dale Taylor, Chris McCaskill, Jaeweon Kim, Rashmi Shah, Mansoor Mohammed, Todd Barry, Brianne Kaiser, Amita Patnaik and Anthony Tolcher
    Citation: Journal of Ovarian Research 2013 6:2
    Content type: Research Published on:

  5. Epithelial Ovarian Cancer (EOC) is the second most common gynaecological cancer and accounts for more deaths than all gynaecological cancers combined. Despite extensive research, progress has ... profiling. Cell ...

    Authors: Thumuluru Kavitha Madhuri, Anil Tailor, Ben Haagsma, Helen Coley and Simon Butler-Manuel
    Citation: Journal of Ovarian Research 2012 5:46
    Content type: Review Published on:

  6. Ovarian cancer is the fifth most common cancer among women and causes more deaths than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is based on the combination of surgery a...

    Authors: Mohd Saif Zaman, Diane M Maher, Sheema Khan, Meena Jaggi and Subhash C Chauhan
    Citation: Journal of Ovarian Research 2012 5:44
    Content type: Review Published on:

  7. Mature cystic teratomas (MCTs) are the most common germ cell tumors of the ovary. Malignant tranformation occurs in 1-2% of these neoplasms. Although most of the malignancies arising from MCTs are squamous cel...

    Authors: Masaaki Takai, Masanori Kanemura, Hiroshi Kawaguchi, Satoe Fujiwara, Saha Yoo, Yoshimichi Tanaka, Satoshi Tsunetoh, Yoshito Terai, Takashi Yamada and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2012 5:41
    Content type: Case report Published on:

  8. Current protocols for the treatment of ovarian cancer include combination chemotherapy with a platinating agent ... However, many patients experience relapse of their cancer and the development of drug resistance...

    Authors: Stephen R Armstrong, Rashmi Narendrula, Baoqing Guo, Amadeo M Parissenti, Katherine L McCallum, Stephanie Cull and Carita Lannér
    Citation: Journal of Ovarian Research 2012 5:40
    Content type: Research Published on:

  10. Epithelial ovarian cancer (EOC) remains the most lethal of ... cell-like features. These cells, termed ‘cancer initiating cells’ or ‘cancer stem cells (CSCs)’ have been shown ... This article reviews the involvem...

    Authors: Chantel Samardzija, Michael Quinn, Jock K Findlay and Nuzhat Ahmed
    Citation: Journal of Ovarian Research 2012 5:37
    Content type: Review Published on:

  11. G protein-coupled receptor 30 (GPR30) is a 7-transmembrane estrogen receptor that functions alongside traditional estrogen receptors to regulate the cellular responses to estrogen. Recent studies suggest that GPR...

    Authors: Satoe Fujiwara, Yoshito Terai, Hiroshi Kawaguchi, Masaaki Takai, Saha Yoo, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, Hiroshi Sasaki, Masanori Kanemura, Akiko Tanabe, Yoshiki Yamashita and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2012 5:35
    Content type: Research Published on:

  12. Resistance to apoptosis is a major problem in ovarian cancer and correlates with poor prognosis. Osteoprotegerin ( ... (TRAIL). TRAIL promotes apoptosis in ovarian cancer cells. Ovarian cancer ascites attenuate T...

    Authors: Denis Lane, Isabelle Matte, Claudine Rancourt and Alain Piché
    Citation: Journal of Ovarian Research 2012 5:34
    Content type: Research Published on:

  14. Follicle stimulating hormone (FSH) exerts action on both germline and somatic compartment in both ovary and testis although FSH receptors (FSHR) are localized only on the somatic cells namely granulosa cells o...

    Authors: Deepa Bhartiya, Kalpana Sriraman, Pranesh Gunjal and Harshada Modak
    Citation: Journal of Ovarian Research 2012 5:32
    Content type: Research Published on:

  17. The global gene regulator Special AT-rich sequence-binding protein1 (SATB1) has been reported to reprogramme tumour cells into a more malignant phenotype and associate with poor clinical outcome in several cancer

    Authors: Björn Nodin, Charlotta Hedner, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:24
    Content type: Brief communication Published on:

  18. Anti-VEGF treatment has proven effective in recurrent ovarian cancer. However, the identification of the patients...

    Authors: Christine Vestergaard Madsen, Karina Dahl Steffensen, Dorte Aalund Olsen, Marianne Waldstrøm, Maja Smerdel, Parvin Adimi, Ivan Brandslund and Anders Jakobsen
    Citation: Journal of Ovarian Research 2012 5:23
    Content type: Research Published on:

  19. Autophagy is a lysosomal-driven catabolic process that contributes to preserve cell and tissue homeostases through the regular elimination of damaged, aged and redundant self-constituents. In normal cells, autoph...

    Authors: Claudia Peracchio, Oscar Alabiso, Guido Valente and Ciro Isidoro
    Citation: Journal of Ovarian Research 2012 5:22
    Content type: Review Published on:

  21. The aim of this study was to assess the clinical value of preoperative blood levels of HE4 as a predictor of overall survival in patients with ovarian cancer and to validate previous data of HE4...

    Authors: Grigorios Kalapotharakos, Christine Asciutto, Emir Henic, Bertil Casslén and Christer Borgfeldt
    Citation: Journal of Ovarian Research 2012 5:20
    Content type: Research Published on:

  23. It is well known that somatotrophic/insulin signaling affects lifespan in experimental animals, and one of the signs of aging is progressive gonadal dysfunction.

    Authors: Sylwia Słuczanowska-Głąbowska, Maria Laszczyńska, Katarzyna Piotrowska, Wojciech Głąbowski, John J Kopchick, Andrzej Bartke, Magda Kucia and Mariusz Z Ratajczak
    Citation: Journal of Ovarian Research 2012 5:18
    Content type: Research Published on:

  24. The addition of bevacizumab to standard chemotherapy prolongs progression free survival in the first line treatment of epithelial ovarian cancer (EOC), but its cost/effectiveness is...

    Authors: Carlotta Defferrari, Sara Campora, Mauro D'Amico, Arnoldo Piccardo, Ennio Biscaldi, Daniela Rosselli, Ambra Pasa, Matteo Puntoni, Alberto Gozza, Alessandra Gennari, Silvia Zanardi, Rita Lionetto, Michela Bandelloni and Andrea DeCensi
    Citation: Journal of Ovarian Research 2012 5:17
    Content type: Research Published on:

  25. Differences in the incidences and types of DNA damage induced by antitumor agents for clear cell carcinoma (CCC) were determined in 2 ovarian CCC cell lines using γH2AX.

    Authors: Eriko Takatori, Tadahiro Shoji, Seisuke Kumagai, Takashi Sawai, Akira Kurose and Toru Sugiyama
    Citation: Journal of Ovarian Research 2012 5:16
    Content type: Research Published on:

  27. New treatment strategies are emerging to target DNA damage response pathways in ovarian cancer. Our group has previously shown that the ... response and has potent cytotoxic effects in ovarian cancer cells. Here,...

    Authors: Andrew J Wilson, Yi-Qiang Cheng and Dineo Khabele
    Citation: Journal of Ovarian Research 2012 5:12
    Content type: Research Published on:

  28. Serum CA125 is routinely used in the follow up of ovarian cancer. The objective of the present study was ... usefulness of CA125 in the detection of ovarian cancer recurrence.

    Authors: Elizabeth Varughese, Srinivas Kondalsamy-Chennakesavan and Andreas Obermair
    Citation: Journal of Ovarian Research 2012 5:11
    Content type: Research Published on:

  29. Struma ovarii is a rare form of ovarian neoplasm in a form of mature teratoma and is composed predominantly of thyroid tissue. In the literature review, there has only been 10 cases of this tumor, associated w...

    Authors: Nahid Mostaghel, Anahita Enzevaei, Khandan Zare and Masoome Fallahian
    Citation: Journal of Ovarian Research 2012 5:10
    Content type: Case report Published on:

  30. GPER mRNA was assayed with quantitative real-time PCR (qPCR) in 42 primary ovarian tumors and 7 ovarian cancer cell lines. ERα and ERβ mRNA were...

    Authors: Zuzana Kolkova, Vera Casslén, Emir Henic, Sara Ahmadi, Anna Ehinger, Karin Jirström and Bertil Casslén
    Citation: Journal of Ovarian Research 2012 5:9
    Content type: Research Published on:

  31. MicroRNAs (miRNAs) are a class of small non-coding RNAs which function in gene regulation with an important role in cell proliferation, maturation, and activity. The regulatory role of these small RNA molecule...

    Authors: Jason Baley and Julang Li
    Citation: Journal of Ovarian Research 2012 5:8
    Content type: Review Published on:

  32. A crucial step in the metastatic spread of ovarian cancer (OC) is the adhesion and implantation...

    Authors: Takafumi Watanabe, Toshihiro Hashimoto, Takashi Sugino, Shu Soeda, Hiroshi Nishiyama, Yutaka Morimura, Hidekazu Yamada, Steve Goodison and Keiya Fujimori
    Citation: Journal of Ovarian Research 2012 5:7
    Content type: Research Published on:

  33. The Dachshund homolog 2 (DACH2...) gene has been implicated in development of the female genital tract in mouse models and premature ovarian failure syndrome, but to date, its expression in human normal and cance...

    Authors: Björn Nodin, Marie Fridberg, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:6
    Content type: Research Published on:

  34. RNA-Seq allows a theoretically unbiased analysis of both genome-wide transcription levels and mutation status of a tumor. Using this technique we sought to identify novel candidate therapeutic targets expressed i...

    Authors: Rebecca A Mosig, Li Lin, Emir Senturk, Hardik Shah, Fei Huang, Peter Schlosshauer, Samantha Cohen, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:4
    Content type: Research Published on:

  35. RNA-Seq was used to quantify papillary serous ovarian cancer transcriptomes. Paired end sequencing of 22 flash...

    Authors: Rebecca A Mosig, Mollie Lobl, Emir Senturk, Hardik Shah, Samantha Cohen, Eugene Chudin, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:3
    Content type: Research Published on:

  36. Malignant ovarian disease is characterised by high rates of mortality due to high rates of recurrent chemoresistant disease. Anecdotal evidence indicates this may be due to chemoresistant properties of cancer ste...

    Authors: Michael F Gallagher, Cynthia CBB Heffron, Alexandros Laios, Sharon A O'Toole, Brendan Ffrench, Paul C Smyth, Richard J Flavin, Salah A Elbaruni, Cathy D Spillane, Cara M Martin, Orla M Sheils and John J O'Leary
    Citation: Journal of Ovarian Research 2012 5:2
    Content type: Research Published on:

  37. Resistance to current chemotherapeutic agents is a major cause of therapy failure in ovarian cancer patients, but the exact mechanisms leading to...

    Authors: Cheryl A Sherman-Baust, Kevin G Becker, William H Wood III, Yongqing Zhang and Patrice J Morin
    Citation: Journal of Ovarian Research 2011 4:21
    Content type: Research Published on:

  38. Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of su...

    Authors: Anna Felisiak-Golabek, Alina Rembiszewska, Iwona K Rzepecka, Lukasz Szafron, Radoslaw Madry, Magdalena Murawska, Tomasz Napiorkowski, Piotr Sobiczewski, Beata Osuch and Jolanta Kupryjanczyk
    Citation: Journal of Ovarian Research 2011 4:20
    Content type: Research Published on:

  39. Glutathione peroxidase 3 (GPX3) is a selenocysteine-containing antioxidant enzyme that reacts with hydrogen peroxide and soluble fatty acid hydroperoxides, thereby helping to maintain redox balance within cells. ...

    Authors: Deep Agnani, Olga Camacho-Vanegas, Catalina Camacho, Shashi Lele, Kunle Odunsi, Samantha Cohen, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2011 4:18
    Content type: Research Published on:

  40. Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide. According to the National Cancer Institute, ovarian cancer has the highest mortality rate among all the reproductive cancers

    Authors: Smriti Kumar, Arooshi Kumar, Parag P Shah, Shesh N Rai, Siva K Panguluri and Sham S Kakar
    Citation: Journal of Ovarian Research 2011 4:17
    Content type: Research Published on:

  41. The HOX genes are a family of homeodomain-containing transcription factors that determine cellular identity during development. Here we review a number of recent studies showing that HOX genes are strongly expres...

    Authors: Zoë L Kelly, Agnieszka Michael, Simon Butler-Manuel, Hardev S Pandha and Richard GL Morgan
    Citation: Journal of Ovarian Research 2011 4:16
    Content type: Review Published on:

  43. Ovarian cancer is sixth most common cancer among women and the leading cause of ... gynecological malignancies. Despite the great impact ovarian cancer has on women's health and its...

    Authors: Marcela F Paes, Renata D Daltoé, Klesia P Madeira, Lucas CD Rezende, Gabriela M Sirtoli, Alice L Herlinger, Leticia S Souza, Luciana B Coitinho, Débora Silva, Murilo F Cerri, Ana Cristina N Chiaradia, Alex A Carvalho, Ian V Silva and Leticia BA Rangel
    Citation: Journal of Ovarian Research 2011 4:14
    Content type: Research Published on:

  44. The presence of oocytes in the ovarian surface epithelium has already been confirmed in the fetal ovaries. We report the presence of SSEA-4, SOX-2, VASA and ZP2-positive primitive oocyte-like cells in the adul...

    Authors: Irma Virant-Klun, Thomas Skutella, Branko Cvjeticanin, Martin Stimpfel and Jasna Sinkovec
    Citation: Journal of Ovarian Research 2011 4:13
    Content type: Case report Published on:

  45. Study of the hen immune system led to seminal contributions to basic immunological principles. Recent studies of spontaneous ovarian cancer in the laying hen show strikingly similar ... types and antigen expressi...

    Authors: Yi Yu, Seby L Edassery, Animesh Barua, Jacques S Abramowicz, Janice M Bahr, Ingegerd Hellstrom and Judith L Luborsky
    Citation: Journal of Ovarian Research 2011 4:12
    Content type: Research Published on:

  46. Endometriosis Health Profile (EHP-5) is a valid instrument to measure health-related quality of life in endometriosis. This study was conducted to culturally adapt and validate the EHP-5 in Iran.

    Authors: Azita Goshtasebi, Maryam Nematollahzadeh, Fatemeh Zahra Hariri and Ali Montazeri
    Citation: Journal of Ovarian Research 2011 4:11
    Content type: Brief communication Published on:

  48. Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer death in the USA. Recurrence rates are...2...) and hyperthermia (43°C) affect mechanisms of cisplatin resistance in ovarian cancer.

    Authors: Clarisse S Muenyi, Vanessa A States, Joshua H Masters, Teresa W Fan, C William Helm and J Christopher States
    Citation: Journal of Ovarian Research 2011 4:9
    Content type: Research Published on:

  49. Recent evidence has suggested that the capability of cancer to grow, propagate and relapse after therapy ... the cell population within the tumor, called cancer stem cells. Therefore, this subpopulation of ... MU...

    Authors: Moorthy P Ponnusamy, Parthasarathy Seshacharyulu, ArokiaPriyanka Vaz, Parama Dey and Surinder K Batra
    Citation: Journal of Ovarian Research 2011 4:7
    Content type: Research Published on:

  50. In the search for unique ovarian cancer biomarkers, ovarian specific cDNA microarray analysis identified ... checkpoint protein, as over-expressed in ovarian cancer. The aim of this study was to...

    Authors: Jennifer L Young, E Colin Koon, Joseph Kwong, William R Welch, Michael G Muto, Ross S Berkowitz and Samuel C Mok
    Citation: Journal of Ovarian Research 2011 4:6
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us